Loading clinical trials...

Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome

ESTUDIO DE APLICACIÓN DE ESCALAS PARA VALORACIÓN SINTOMÁTICA DEL SÍNDROME DE COVID PERSISTENTE

NCT06879535•Hospital del Rio Hortega

Summary

The goal of this observational study is to learn about the long-term evolution of long COVID. The main question it aims to answer is: Does the main symptoms of the patients diagnosed with long COVID aproximate to those of patients who have had COVID acute infection without devoloping long COVID? Participants will answer mailed survey questions about their main symptons.

Detailed Description

Scales, indexes and questionnaires were mailed to 40 patients with long COVID to evaluate their main symptoms. Fatigue, emotional disorders, sleep disorders, cognitive impairments, dyspnea, physical activity, quality of life and pain were analyzed. The patients were reassessed after three years. The same scales, indexes and questionnaires were also sent to a control group of 40 volunteers of the same age and sex as the cases.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•patients older than 18 years old and younger than 75 years old
•patients who accepted to participate in the study
•patients who have had COVID acute infection
•patients who have long COVID (cases)

Exclusion Criteria

•patients who refused to participate in the study at any time of the study
•patients whose diagnosis of long COVID was revoked during the study (cases)

Locations (1)

Hospital Universitario Río Hortega

Valladolid, Valladolid, Spain

Key Dates

Start Date

March 28, 2022

Primary Completion Date

March 28, 2025

Completion Date

March 28, 2025

Last Updated

March 17, 2025

Enrollment

ACTUAL participants

Conditions

Long COVID

Taurine Supplementation in Long COVID

NCT06721949

Long COVID

View study

RECRUITINGPHASE3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome

Inclusion Criteria

Exclusion Criteria

Taurine Supplementation in Long COVID

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

A Study to Examine Anktiva for the Treatment of COVID-19.